Search
Search Results
##search.searchResults.foundPlural##
-
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2034PDF: 744HTML: 690Table1: patient's characteristics: 162Table 2: profile of each patient: 186 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2499PDF: 895HTML: 2472 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4504PDF: 1749HTML: 1109 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1125PDF: 647HTML: 426 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
9018PDF: 3281HTML: 1410 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2061PDF: 828HTML: 229 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2064PDF: 817HTML: 1148 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
978PDF: 577HTML: 2203Cover Letter: 202 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3340PDF: 968HTML: 2972 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
836PDF: 547HTML: 4026 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4067PDF: 1563HTML: 9194Untitled: 287Untitled: 195Untitled: 180Untitled: 173Untitled: 196Untitled: 352 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2690PDF: 973HTML: 3651 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2721PDF: 964HTML: 563 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7898PDF: 738HTML: 224 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2591PDF: 864HTML: 8919Efremov 1: 244Efremov 2: 208 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
134PDF: 137HTML: 9 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1910HTML: 1511PDF: 1126 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4899PDF: 2898HTML: 2323 -
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1720PDF: 1273HTML: 397 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1409PDF: 1039HTML: 374Suppl. Figure: 190Suppl. Tables: 213 -
WHAT ARE FUNGAL INFECTIONS?
4276PDF: 2442HTML: 27646de Pauw: 252 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2515HTML: 292PDF: 920 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
778PDF: 675HTML: 108 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1612PDF: 1065HTML: 263 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1863PDF: 838HTML: 10250Figures 1,2,3: 202 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1063PDF: 561HTML: 7821 -







